Abstract
The aims of this study were: (1) to compare the diagnostic efficacy for celiac disease (CD) diagnosis of serum determination of anti‐gliadin (AG) (IgA and IgG) and anti‐endomysium (AE) with that of anti‐transglutaminase (AtTG); and (2) to compare the accuracy of four different assays to measure AtTG. We studied 72 children: the histological diagnosis of CD was made in 38 cases and excluded in the remaining 34 children. In fasting sera we measured AE, AG‐IgA and IgG, and AtTG, the latter with four different commercial kits (Eurospital, Medipan, Inova, Arnika). Moreover AtTG was measured in a group of 58 CD children after a gluten‐free diet. AE was positive in all but 1 case of CD patients (sensitivity = 97%); false positive results were found in 1/34 controls (specificity = 97%). When a specificity of 95% was fixed, the sensitivities were 97% for AE, 83% for AG‐IgA, and 63% for AG‐IgG; the sensitivities of anti‐tTG were 90, 84, 84, and 75% when measured with Eurospital, Medipan, Inova, and Arnika kits respectively. The new AtTG seems to be accurate enough to be proposed as a noninvasive diagnostic tool for CD diagnosis; the 4 kits analyzed showed similar diagnostic efficacy. J. Clin. Lab. Anal. 15:112–115, 2001. © 2001 Wiley‐Liss, Inc.
Keywords: gluten, ELISA, children
REFERENCES
- 1. Dieterich W, Ehnis T, Bauer M, et al. 1997. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3:797–801. [DOI] [PubMed] [Google Scholar]
- 2. Marsh MN. 1997. Transglutaminase, gluten and celiac disease: food for thought. Nat Med 3:725–726. [DOI] [PubMed] [Google Scholar]
- 3. Sollid LM, Thorsby E. 1993. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105:910–922. [DOI] [PubMed] [Google Scholar]
- 4. Quarsten H, Molberg Ø, Fugger L, McAdam SN, Sollid LM. 1999. HLA binding and T cell recognition of a tissue transglutaminase‐modified gliadin epitope. Eur J Immunol 29:2506–2514. [DOI] [PubMed] [Google Scholar]
- 5. Mcdam SN, Körner R, et al. 1998. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut‐derived T cells in celiac disease. Nat Med 4:713–794. [DOI] [PubMed] [Google Scholar]
- 6. van de Wal Y, Kooy Y, van Veelen P, et al. 1998. Cutting edge: selective deamidation by tissue transglutaminase strongly enhances gliadin‐specific T cell reactivity. J Immunol 161:1585–1588. [PubMed] [Google Scholar]
- 7. van de Wal Y, Kooy YMC, van Veelen PA, et al. 1998. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci U S A 95:10050–10054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Sollid LM, Molberg Ø, McAdam S, Lundin KEA. 1997. Autoantibodies in coeliac disease: tissue transglutaminase‐guilt by association? Gut 41:851–852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Schuppan D, Dieterich W, Riecken EO. 1998. Exposing gliadin as a tasty food for lymphocytes. Deamidation of wheat gliadin by tissue transglutaminase promotes its binding to HLA‐DQ2 and its recognition by gut T cells, suggesting a novel mechanism in celiac disease. Nat Med 4:666–667. [DOI] [PubMed] [Google Scholar]
- 10. Troncone R, Ferguson A. 1991. Anti‐gliadin antibodies. J Pediatr Gastroenterol Nutr 12:150–158. [DOI] [PubMed] [Google Scholar]
- 11. Collin P. 1998. Serologic screening for coeliac disease‐time for tissue transglutaminase test? Ital J Gastroenterol Hepatol 30:498–499. [PubMed] [Google Scholar]
- 12. Brusco G, Izzi L, Corazza GR. 1998. Tissue transglutaminase antibodies for coeliac disease screening. Ital J Gastroenterol Hepatol 30:496–497. [PubMed] [Google Scholar]
- 13. Dieterich W, Laag E, Schopper H, et al. 1998. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115:1317–1321. [DOI] [PubMed] [Google Scholar]
- 14. Sulkanen S, Halttunen T, Laurila A, et al. 1998. Tissue transglutaminase autoantibody enzyme‐linked immunosorbent assay in detecting celiac disease. Gastroenterology 115:1322–1328. [DOI] [PubMed] [Google Scholar]
- 15. Sollid LM, Scott H. 1998. New tool to predict celiac disease on its way to the clinics. Gastroenterology 115:1584–1586. [DOI] [PubMed] [Google Scholar]
- 16. Biagi F, Ellis HJ, Yiannakou JY, et al. 1999. Tissue transglutaminase antibodies in celiac disease. J Gastroenterol 94:2187–2192. [DOI] [PubMed] [Google Scholar]
- 17. Miller A, Elliott PR, Paspaliaris W, d’Apice A. 1999. Anti‐tranglutaminase antibodies and coeliac disease. Aust NZ J Med 29:239–242. [DOI] [PubMed] [Google Scholar]